Technology

Latest Issue of OR Manager
June 2019

FDA grants Stryker premarket approval for intracranial aneurysm stent

Editor's Note Stryker announced on May 20 that the Food & Drug Administration (FDA) granted premarket approval for its Neuroform Atlas stent system for intracranial aneurysms, the May 20 MassDevice reports.   The self-expanding nitinol stent can now be used with neurovascular embolization coils to treat patients with saccular wide-necked…

Read More

By: Judy Mathias
May 23, 2019
Share

FDA letter updates mortality risk in patients receiving Abiomed Impella RP System

Editor's Note The Food and Drug Administration (FDA) on May 21 released a letter to healthcare professionals about the most recent, interim post-approval study (PAS) results for the Abiomed Impella RP System, a percutaneous heart pump for right heart support.   The latest interim results show a lower survival rate…

Read More

By: Judy Mathias
May 22, 2019
Share

FDA issues warning on use of unauthorized devices for diabetes management

Editor's Note The Food & Drug Administration (FDA) on May 17 issued a warning to patients and healthcare professionals on the risks associated with the use of unapproved or unauthorized devices for diabetes management, including continuous glucose monitoring systems, insulin pumps, and automated insulin dosing systems. The use of these…

Read More

By: Judy Mathias
May 20, 2019
Share

How will artificial intelligence impact surgical patient care? Part 2

As part of a special series on artificial intelligence (AI), OR Manager is taking a deep dive into the many facets of this new technology and its impact on patient care. Part 1 of this introduction to the series (OR Manager, May 2019, 1, 7-11) defined several different types of…

Read More

By: Cynthia Saver, MS, RN
May 17, 2019
Share

Artificial intelligence makes surgical 'black box' smarter

Perioperative services departments have been slow to adopt the black boxes used in the aviation industry, partly because it can take a large team of experts hours to analyze data collected by the box. However, the team behind a surgical black box is using artificial intelligence (AI) to significantly cut…

Read More

By: Cynthia Saver, MS, RN
May 17, 2019
Share

Cardiology services: The next wave in ASCs?

Many experts see cardiovascular (CV) care as the next wave in ambulatory surgery centers (ASCs), and a hybrid office-based lab (OBL)/ASC model is gaining momentum across the country. Robert J. Zasa, MSHHA, FACMPE, president and CEO of Ambulatory Systems Development, LLC, in Incline Village, Nevada, sees the hybrid arrangement as…

Read More

By: Jennifer Lubell
May 17, 2019
Share

Patient, surgeon outcomes reporting app helps predict success of ventral hernia repair

Editor's Note Researchers have developed an online app that patients and surgeons can use to guide preoperative planning and provide predictive data for how a patient’s ventral hernia repair will turn out. The basis of the app is a tool named the “Outcomes Reporting App for CLinical and Patient Engagement”…

Read More

By: Judy Mathias
May 8, 2019
Share

Use of TAVR in low-risk patients

Editor's Note In this study of low-risk patients with severe aortic stenosis, outcomes were significantly better at 1 year follow-up with transcatheter aortic-valve replacement (TAVR) than surgical aortic-valve replacement. In 1,000 patients at 71 centers who were randomized to undergo either TAVR or surgical aortic-valve replacement, the rate of the…

Read More

By: Judy Mathias
May 2, 2019
Share

Off-label use of simethicone, lubricants, and tissue glue contributes to endoscope reprocessing failures

Editor's Note The off-label use of defoaming agents, lubricants, and tissue glue is common, and these insoluable substances are not removed during reprocessing, this study finds. Of 69 fully reprocessed endoscopes examined in four hospitals, microbial cultures were positive for 50% or more. The researchers, led by Cori Ofstead, MSPH,…

Read More

By: Judy Mathias
April 23, 2019
Share

FDA announces new efforts to protect patients from risks associated with surgical staplers, implantable staples

Editor's Note The Food & Drug Administration on April 23 announced new steps it will be taking to help reduce risks associated with surgical staplers for internal use and implantable staples. The proposed steps include: Reclassifying surgical staplers from Class I (low risk) to Class II (moderate risk). Issuing guidance to…

Read More

By: Judy Mathias
April 23, 2019
Share
OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat